| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$232,504 |
|
|
|
Indirect Value
|
$203,423 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$435,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-11 |
4 |
AS |
$21.49 |
$438,900 |
I/I |
(20,000) |
360,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-12 |
4 |
AS |
$30.05 |
$3,005 |
I/I |
(100) |
360,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-16 |
4 |
AS |
$30.38 |
$18,228 |
I/I |
(600) |
359,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-22 |
4 |
AS |
$30.93 |
$330,735 |
I/I |
(10,000) |
349,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-23 |
4 |
AS |
$34.05 |
$859,606 |
D/D |
(24,100) |
325,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-24 |
4 |
AS |
$33.20 |
$486,938 |
D/D |
(14,400) |
310,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-25 |
4 |
AS |
$33.22 |
$340,976 |
I/I |
(10,000) |
300,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-26 |
4 |
AS |
$35.46 |
$339,558 |
I/I |
(9,300) |
291,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
808,675 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-08 |
4 |
AS |
$37.15 |
$163,460 |
I/I |
(4,400) |
287,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-09 |
4 |
AS |
$36.59 |
$165,969 |
I/I |
(4,400) |
282,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-13 |
4 |
AS |
$45.10 |
$451,000 |
I/I |
(10,000) |
272,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-14 |
4 |
AS |
$45.05 |
$484,956 |
I/I |
(10,000) |
262,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,938 |
812,613 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-15 |
4 |
AS |
$45.58 |
$468,789 |
I/I |
(10,000) |
252,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-16 |
4 |
AS |
$45.44 |
$469,670 |
I/I |
(10,000) |
242,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-20 |
4 |
AS |
$45.28 |
$393,936 |
I/I |
(8,700) |
234,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-21 |
4 |
AS |
$43.60 |
$198,965 |
I/I |
(4,500) |
229,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-22 |
4 |
AS |
$42.74 |
$201,832 |
I/I |
(4,600) |
225,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-12 |
4 |
AS |
$46.17 |
$46,314 |
I/I |
(1,000) |
224,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-15 |
4 |
AS |
$41.87 |
$185,956 |
I/I |
(4,400) |
219,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-16 |
4 |
AS |
$41.75 |
$184,792 |
I/I |
(4,400) |
215,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-26 |
4 |
AS |
$39.72 |
$176,448 |
I/I |
(4,400) |
210,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-27 |
4 |
AS |
$36.63 |
$155,421 |
I/I |
(4,200) |
206,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-27 |
4 |
AS |
$38.40 |
$7,680 |
D/D |
(200) |
206,478 |
0 |
- |
|
209 Records found
|
|
Page 6 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
